[Experience with the vaccine-drug therapy of brucellosis accompanied by changes in the state of allergic reactivity].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use; D002004:Brucella Vaccine / Q000627:therapeutic use*; D002006:Brucellosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006168:Guinea Pigs; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D006967:Hypersensitivity / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D011343:Procaine / Q000627:therapeutic use; D011749:Pyrogens / Q000627:therapeutic use; D013963:Thyroid Hormones / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D002004:Brucella Vaccine; D011749:Pyrogens; D013963:Thyroid Hormones; D014815:Vitamins; D011343:Procaine; D007611:Aprotinin; D011239:Prednisolone; D006821:Hyaluronoglucosaminidase
Opyt vaktsinno-medikamentoznoĭ terapii bol'nykh brutsellezom s izmeneniiami v sostoianii allergicheskoĭ reaktivnosti.